The report provides a detailed analysis essential for establishing a Prussian Blue production plant. It encompasses all critical aspects necessary for Prussian Blue production, including the cost of Prussian Blue production, Prussian Blue plant cost, Prussian Blue production costs, and the overall Prussian Blue production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Prussian Blue production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Prussian Blue, also known as ferric hexacyanoferrate(II), is an inorganic compound that serves as an important pharmaceutical antidote. It is used for treating internal contamination from radioactive caesium-137 and thallium poisoning. It works by irreversibly binding these monovalent cations within its stable crystal lattice structure and leads to safe faecal excretion that reduces their biological half-life.
It is administered orally as insoluble capsules or powder and exchanges potassium ions for toxic metals, trapping them until elimination. It is also utilised in diagnostic staining for hemosiderin in urine to diagnose G6PD deficiency, and its nanoscale analogues are utilised in biomedicine. Its common side effects include constipation, abdominal pain or distension, nausea, vomiting, hypokalemia (low potassium), and blue stools.
The market for Prussian Blue is driven by its pharmaceutical role as an antidote for thallium and radioactive caesium poisoning. Its government stockpiling for radiological emergencies, and expanding pigment demand in paints, inks, and battery applications contribute to its market growth. The rising healthcare preparedness in regions like North America and India, with better infrastructure and energy storage innovations, boosts its demand.
The need for GMP-certified suppliers, required USDMF and CEP certifications, COA and MSDS documentation, and purity above 99% for pharma-grade material affects industrial Prussian Blue procurement. Other factors like pricing volatility from raw material costs, synthesis complexity, and limited global supply chains impact its sourcing.
Raw Material for Prussian Blue Production
According to the Prussian Blue production plant project report, the key raw materials used in the production of Prussian Blue include Iron(III) chloride and Potassium Ferrocyanide.
Production Process of Prussian Blue
The extensive Prussian Blue production cost report consists of the following major industrial production process:
- From Iron(III) chloride and Potassium Ferrocyanide: The production process of Prussian Blue involves preparing a saturated solution of iron(III) chloride. A separate saturated solution of potassium ferrocyanide is made, which is added to the ferrocyanide solution in the ferric chloride solution. This produces a deep blue gelatinous precipitate of Prussian Blue. The reaction mixture is poured into the wetted filter paper under suction to transfer all the product. Finally, the product is air-dried to get pure Prussian Blue as the final product.
Prussian Blue has the molecular formula of Fe4[Fe(CN)6]3 · xH2O and a molecular weight of around 859 g/mol. It appears as a dark blue to purple fine powder with a density of 1.75-1.80 g/cm³. It shows very low solubility in water or ethanol but is soluble in oxalic acid or alkaline solutions. It decomposes upon light exposure or heating and features a face-centred cubic crystal lattice with Fe(II)–C and Fe(III)–N bonds. It remains stable under normal conditions yet oxidises and reduces reversibly due to mixed Fe²+/Fe³+ valences. It contains interstitial water or cations influencing its colloidal behaviour and ion-exchange capacity for medical uses like thallium and caesium chelation.